Navigation Links
Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
Date:9/6/2013

New York, NY (PRWEB) September 06, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that, according to a Sept. 4 Bloomberg report, during a trial over the diabetes drug Actos, a lawyer for the Plaintiff alleged Takeda Pharmaceutical Co. had failed to warn consumers about certain cancer risks related to the drug (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland).

Takeda officials knew by 2005 that studies had shown links between Actos and cancer and didn’t issue a warning until six years later, the lawyer alleged in opening arguments, according to the Bloomberg report.

The U.S. Food and Drug Administration (FDA), which approved Actos, has been warning of the risks of the drug since 2011. On June 15, 2011, the agency said that taking Actos for more than a year could significantly increase the risk of bladder cancer. The safety label on Actos was updated to address this risk.

“The FDA was among the first to determine the drug Actos can cause an elevated risk in bladder cancer among those who take it for around a year,” said Parker Waichman LLP. “At least now we seem to be on the same page about the potential dangers associated with this drug.”

Aside from the FDA, research studies from other groups provide additional support for the notion of a link between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012, that revealed Actos users were twice as likely to develop bladder cancer after two years. Then, on July 3, 2012, the Canadian Medical Association Journal reported that patients taking the medication were 22 percent more likely to get bladder cancer.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by Actos, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636

Read the full story at http://www.prweb.com/releases/Actos_trial_Bloomberg/09/prweb11098139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Knee Sleeve Lawsuits Help: Resource4thePeople Expands Recall Reviews to include both Knee and Hip Cases
2. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order and Stipulation in Federal Biomet Hip Replacement Litigation
3. DePuy Pinnacle Lawsuit News: Claims Filed in Federal DePuy Pinnacle Hip Litigation Approach 5,000, Bernstein Liebhard LLP Reports
4. Mirena IUD Lawsuit Help: Resource4thePeople Reports Number of Consolidated Cases Increases as Litigation Advances
5. C8 Lawsuit Lawyers at Wright & Schulte LLC Applaud Scheduling of First Trials in Multidistrict Litigation Established for Federal DuPont C8 Lawsuits
6. Actos Lawsuit News: Bernstein Liebhard LLP Notes Start of Second Actos Bladder Cancer Trial in Maryland State Court
7. Da Vinci Surgery Lawsuit News: Bernstein Liebhard LLP Comments on New Research that Suggests Robotic Surgery Complications Underreported
8. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
9. Transvaginal Mesh Lawsuits Help: Resource4thePeople Reports Key Trials Scheduled in Consolidated Federal Cases as Number of Cases Increases
10. Biomet Hip Lawsuits News: Judge Denies Biomet Motion to Dismiss Lawsuit, Reports Rottenstein Law Group LLP
11. NuvaRing Lawsuit Filed by Alonso Krangle Alleges That Use of NuvaRing Caused a Louisiana Woman to Develop a Life-Threatening Blood Clot Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: